Cargando…

Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy

Oncogene-induced STAT3-activation is central to tumor progression by promoting cancer cell expression of pro-angiogenic and immunosuppressive factors. STAT3 is also activated in infiltrating immune cells including tumor-associated macrophages (TAM) amplifying immune suppression. Consequently, STAT3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verdeil, Grégory, Lawrence, Toby, Schmitt-Verhulst, Anne-Marie, Auphan-Anezin, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966642/ https://www.ncbi.nlm.nih.gov/pubmed/31766350 http://dx.doi.org/10.3390/cancers11121832

Ejemplares similares

IFNγ producing CD8(+) T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas
por: Buferne, Michel, et al.
Publicado: (2015)

Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019)

Disrupted Lymph Node and Splenic Stroma in Mice with Induced Inflammatory Melanomas Is Associated with Impaired Recruitment of T and Dendritic Cells
por: Soudja, Saïdi M., et al.
Publicado: (2011)

Targeting STAT3 in Cancer Immunotherapy
por: Zou, Sailan, et al.
Publicado: (2020)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

Direct Targeting Options for STAT3 and STAT5 in Cancer
por: Orlova, Anna, et al.
Publicado: (2019)

Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
por: Etzerodt, Anders, et al.
Publicado: (2020)

Identification of STAT5A and STAT5B Target Genes in Human T Cells
por: Kanai, Takahiro, et al.
Publicado: (2014)

STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
por: Logotheti, Stella, et al.
Publicado: (2019)

Tracking Dynamics of Spontaneous Tumors in Mice Using Photon-Counting Computed Tomography
por: Cassol, Franca, et al.
Publicado: (2019)

Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
por: Kitamura, Hidemitsu, et al.
Publicado: (2017)

In vivo identification of novel STAT5 target genes
por: Basham, Beth, et al.
Publicado: (2008)

STAT5 and CD4 (+) T Cell Immunity
por: Owen, David L., et al.
Publicado: (2017)

STAT3 and STAT5 Activation in Solid Cancers
por: Igelmann, Sebastian, et al.
Publicado: (2019)

Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice
por: Bintz, Jennifer, et al.
Publicado: (2020)

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
por: Brachet-Botineau, Marie, et al.
Publicado: (2020)

Targeting the JAK/STAT pathway in solid tumors
por: Qureshy, Zoya, et al.
Publicado: (2020)

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
por: Mohanty, Sambit K., et al.
Publicado: (2017)

Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022)

Companion Animals as Models for Inhibition of STAT3 and STAT5
por: Kieslinger, Matthias, et al.
Publicado: (2019)

BCR-ABL Affects STAT5A and STAT5B Differentially
por: Schaller-Schönitz, Michael, et al.
Publicado: (2014)

Phosphorylated Forms of STAT1, STAT3 and STAT5 Are Expressed in Proliferating but Not Involuted Infantile Hemangioma
por: Sulzberger, Lucy, et al.
Publicado: (2018)

Targeting the tumor microenvironment: JAK-STAT3 signaling
por: Bournazou, Eirini, et al.
Publicado: (2013)

Direct targets of pSTAT5 signalling in erythropoiesis
por: Gillinder, Kevin R., et al.
Publicado: (2017)

Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
por: Shi, Lewis Zhichang, et al.
Publicado: (2021)

Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation
por: Willi, Michaela, et al.
Publicado: (2016)

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
por: Able, Ashley A., et al.
Publicado: (2017)

STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
por: Maurer, Barbara, et al.
Publicado: (2019)

Lyssavirus P-protein selectively targets STAT3-STAT1 heterodimers to modulate cytokine signalling
por: Harrison, Angela R., et al.
Publicado: (2020)

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells
por: Hallal, Rawan, et al.
Publicado: (2020)

Targeting gliomas with STAT3-silencing nanoparticles
por: Kadiyala, Padma, et al.
Publicado: (2021)

Escorting STAT5A
por: LeBrasseur, Nicole
Publicado: (2004)

Involvement of STAT5 in Oncogenesis
por: Halim, Clarissa Esmeralda, et al.
Publicado: (2020)

Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
por: Yu, Xiaokui, et al.
Publicado: (2015)

TGF-β co-opts STAT3-STAT4 signaling to promote human T follicular helper cell differentiation
por: Schmitt, Nathalie, et al.
Publicado: (2014)

The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
por: Shi, Aiping, et al.
Publicado: (2015)

The Expression of STAT3 and STAT5A Genes in Severe Refractory Asthma
por: Saeedfar, Kayvan, et al.
Publicado: (2017)

Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
por: de Araujo, Elvin D., et al.
Publicado: (2019)

Targeting STAT6 in PMBL
por: Leroy, Karen, et al.
Publicado: (2014)

Combined regulation of pro-inflammatory cytokines production by STAT3 and STAT5 in a model of B. pertussis infection of alveolar macrophages
por: Khiter, Fethi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bq0vpjb57i7udp515nnino29l5